Search Within

Christopher King

Formats
  1. Meeting Abstract (18)
  2. Journal Article (13)
Groups
  1. Center for Hematologic Malignancies (31)
  2. Department of Medicine (31)
  3. Executive Committee, Center for Hematologic Malignancies (31)
  4. GSK Faculty (31)
  5. Hematologic Malignancies, Division of (31)
  6. Immunology Program Faculty (31)

More Groups

People
  1. David Suh (31)
  2. Marcel Van Den Brink (31)
  3. Odette Smith (29)
  4. Sydney Lu (25)
  5. Amanda Holland (20)
  6. Robert Jenq (17)

More People

Years
  1. 2011 (2)
  2. 2010 (5)
  3. 2009 (10)
  4. 2008 (8)
  5. 2007 (5)
  6. 2006 (1)
Publications
  1. Blood (15)
  2. Biology of Blood and Marrow Transplantation (9)
  3. Journal of Immunology (2)
  4. Bone Marrow Transplantation (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Elsevier Inc. (9)
  3. Nature Publishing Group (2)
  4. The American Association of Immunologists, Inc (2)
  5. American Society for Clinical Investigation (1)
  6. Oxford University Press (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibition of vasculogenesis ameliorates GvHD and tumours after allo-BMT
    Meeting Abstract

    Penack, O.; Henke, E.; Suh, D.; King, C.; Smith, O.; Na, I. K.; Holland, A.; Ghosh, A.; Lu, S.; Jenq, R.; more...
    Bone Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules fas ligand and trail, the trafficking molecules Ccr9, 7 integrin and psgl1, and the immune modulating molecules ox40 and ceacam1 are required for thymic graft-versus-host disease
    Meeting Abstract

    Lu, S. X.; Na, I. K.; Goldberg, G. L.; Ghosh, A.; Hirschhorn-Cymerman, D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; more...
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Ceacam1 regulates experimental graft-versus-host-disease
    Meeting Abstract

    Lu, S. X.; Willis, L.; Charbonneau Allard, A. M.; Atallah, R.; Holland, A. M.; Turbide, C.; Hubbard, V. M.; Rotolo, J. A.; Smith, O. M.; Suh, D.; more...
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease
    Journal Article

    Rotolo, J. A.; Stancevic, B.; Lu, S. X.; Zhang, J.; Suh, D.; King, C. G.; Kappel, L. W.; Murphy, G. F.; Liu, C.; Fuks, Z.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • IL-17 contributes to CD4-mediated graft-versus-host disease
    Journal Article

    Kappel, L. W.; Goldberg, G. L.; King, C. G.; Suh, D. Y.; Smith, O. M.; Ligh, C.; Holland, A. M.; Grubin, J.; Mark, N. M.; Liu, C.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
    Journal Article

    Jenq, R. R.; King, C. G.; Volk, C.; Suh, D.; Smith, O. M.; Rao, U. K.; Yim, N. L.; Holland, A. M.; Lu, S. X.; Zakrzewski, J. L.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Luteinizing hormone-releasing hormone enhances T cell recovery following allogeneic bone marrow transplantation
    Journal Article

    Goldberg, G. L.; King, C. G.; Nejat, R. A.; Suh, D. Y.; Smith, O. M.; Bretz, J. C.; Samstein, R. M.; Dudakov, J. A.; Chidgey, A. P.; Chen-Kiang, S.; more...
    Journal of Immunology (2009)

    Fulltext@MSK | Save
  • Off-the-shelf tumor immunotherapy with genetically enhanced allogeneic T-cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Depletion of vascular endothelial progenitor cells inhibits inflammation
    Meeting Abstract

    Penack, O.; Henke, E.; Suh, D.; King, C.; Smith, M. O.; Na, I. K.; Holland, A.; Ghosh, A.; Lu, S. X.; Jenq, R.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules Fas ligand and TRAIL, the trafficking molecules CCR9, β7 integrin and PSGL-1, and the immune modulating molecules OX40, CEACAM1, and CTLA4 are required for thymic graft-versus-host disease
    Meeting Abstract

    Na, I. K.; Lu, S. X.; Goldberg, G. L.; Hirschhorn Cymerman, D. D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; Holland, A. M.; more...
    Blood (2008)

    Fulltext@MSK | Save